How does IGF-1 LR3 work?
Research overview of how IGF-1 LR3 works at the molecular level — its proposed mechanism of action, what the published research shows, and where the gaps are.
Proposed mechanism of IGF-1 LR3
A synthetic modified analogue of human IGF-1 with extended half-life, studied in cell-proliferation, myocyte-pathway, and tissue-research literature.
Research on IGF-1 LR3 focuses on how the peptide interacts with specific biological targets in vitro and in laboratory animal models. Because IGF-1 LR3 is sold strictly for research use, the mechanism is discussed here only in the context of published scientific literature — not as any suggestion of human efficacy.
What the research literature describes
What is IGF-1 LR3?
IGF-1 LR3 is a modified version of IGF-1 with a 13-amino acid extension that prevents binding to IGF-binding proteins, resulting in enhanced bioactivity and a longer half-life.
What is IGF-1 LR3 researched for?
Published preclinical research has examined IGF-1 LR3 in cell-proliferation, myocyte-pathway, and PI3K/Akt signalling studies. The extended half-life makes it useful in protocols requiring sustained in-vitro receptor engagement.
What purity does Peptify supply?
Peptify IGF-1 LR3 is 99%+ HPLC-verified, with a batch-specific Janoshik Analytical Certificate of Analysis downloadable from the product page.
Researchers working with IGF-1 LR3 typically combine multiple analytical techniques — HPLC for purity, mass spectrometry for identity confirmation, and sometimes NMR for structural verification — before beginning any experimental protocol.
Important research limitations
Most published research on novel peptides is preclinical: conducted in cell lines, tissue samples, or animal models. Results from preclinical research do not automatically translate to human outcomes, and no peptide sold for research use is a substitute for an MHRA-approved medicine. All Peptify products are "for research use only" per UK regulations.
Buy IGF-1 LR3 for research
99%+ HPLC-verified IGF-1 LR3 in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
What is IGF-1 LR3?
IGF-1 LR3 is a modified version of IGF-1 with a 13-amino acid extension that prevents binding to IGF-binding proteins, resulting in enhanced bioactivity and a longer half-life.
What is IGF-1 LR3 researched for?
Published preclinical research has examined IGF-1 LR3 in cell-proliferation, myocyte-pathway, and PI3K/Akt signalling studies. The extended half-life makes it useful in protocols requiring sustained in-vitro receptor engagement.
What purity does Peptify supply?
Peptify IGF-1 LR3 is 99%+ HPLC-verified, with a batch-specific Janoshik Analytical Certificate of Analysis downloadable from the product page.